ZOLADEX

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug ZOLADEX contains one active pharmaceutical ingredient (API):

1 Goserelin UNII 6YUU2PV0U8 - GOSERELIN ACETATE

Goserelin is a synthetic analogue of naturally occurring LHRH. On chronic administration goserelin results in inhibition of pituitary LH secretion leading to a fall in serum testosterone concentrations in males and serum estradiol concentrations in females. Read about Goserelin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZOLADEX Implant, in pre-filled syringe	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02AE03	Goserelin	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1454M, 8093Y
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502320020033607, 502320020033707
Country: CA	Health Products and Food Branch	Identifier(s): 02049325, 02225905
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 21.293-1-07-04, 6060-MEE-0321
Country: EE	Ravimiamet	Identifier(s): 1002621
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58603, 61367, R-7832
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 005363, 412049
Country: FR	Base de données publique des médicaments	Identifier(s): 66669173, 67037162
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 147364, 180698, 186210, 200328, 24811, 24817, 368902, 369183, 369185, 373940, 373952, 379748
Country: HK	Department of Health Drug Office	Identifier(s): 31178, 42691
Country: IE	Health Products Regulatory Authority	Identifier(s): 88000, 88230, 88231, 88325, 88392, 88423, 88962
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4312, 4313
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499406G1025, 2499406G2021, 2499406G3028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002049, 1002050
Country: MT	Medicines Authority	Identifier(s): MA046/02801, MA046/02802
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 537M89
Country: NG	Registered Drug Product Database	Identifier(s): A4-5399
Country: NL	Z-Index G-Standaard	Identifier(s): 14304198, 14304201
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 26786, 41319
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4650, 4652
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100074722, 100084413
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65081001, W65082001
Country: SG	Health Sciences Authority	Identifier(s): 01506P, 09793P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5683091H, 5683092H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699786880016, 8699786880023
Country: US	FDA, National Drug Code	Identifier(s): 50090-3466, 70720-950, 70720-951